UK scientists say an experimental Bundibugyo Ebola vaccine could reach trials within months

Published by Albis · 10 Jun 2026

A workable vaccine pathway would materially improve the medium-term response outlook for a strain with no approved vaccine

• • A workable vaccine pathway would materially improve the medium-term response outlook for a strain with no approved vaccine.
• • Public-health transmission chain.
• • Bundibugyo Ebola are dealing with a sharper public-health signal.
• • The immediate pressure point is Bundibugyo Ebola, because that is where the event starts producing visible consequences.